Title is a little bit odd but nonetheless eyecatching courtesy of the Shenzhen Post comes news of a new digital pathology diagnosis network platform as part of a cancer care network. With an increasing number of hospital networks, cancer cooperatives and declining reimbursements leading to some consolidation of laboratory services in the U.S. look for more of this to happen with digital pathology leveraging resources.
“Peking University Shenzhen Hospital signed a bilateral cooperation agreement with Japan’s clear hospital cancer research. The two sides will set up pathological remote consultation center based on digital pathology diagnosis network platform.
After more than one year’s previous preparation, the two sides will set up pathological remote consultation center based on digital pathology diagnosis network platform, with the expectation that making use of the advanced cancer diagnosis and treatment and pathological diagnosis technology to increase the accuracy of diagnosis of difficult cases.
It is known that Japan’s clear hospital cancer research was set up in 1934. It is the first cancer special hospital. It mergers medical treatment, teaching together with scientific research.it dedicates to the prevention, early detection and early treatment of tumor.”